Takayasu arteritis

Common Name(s)

Takayasu arteritis, Takayasu's arteritis, TAK, Pulseless disease, Aortic arch syndrome

Takayasu’s arteritis is a rare form of blood vessel inflammation (vasculitis) that typically affects the large artery that carries blood from your heart to the rest of your body (the aorta), as well as the artery that carries blood from the heart to the lungs (pulmonary artery). Signs and symptoms of Takayasu’s arteritis often occur in two stages. The first stage (systemic stage) may include symptoms such general fatigue, fever, headache, fast and unintentional weight loss, joint pain and sore muscles. The second stage (occlusive stage) develops when inflammation causes the affected arteries to narrow. This narrowing can cause a decrease in blood flow along with a decrease in the amount of oxygen and nutrients that can reach tissues and organs. Symptoms of the second stage can include dizziness, visual problems, shortness of breath, chest or abdominal pain, weakness, change in limb color, fainting, stroke, seizure, or high blood pressure. Symptoms depend on which arteries are inflamed.

The exact cause of Takayasu’s arteritis is not known. The inflamed arteries are believed to be caused by an autoimmune disease, which means the body’s immune cells attack the tissue in the arteries, mistaking it for something foreign (from outside the body). To diagnose the condition, a doctor will collect a medical history, conduct a physical exam, perform blood tests and collect images of the heart, chest and arteries. In some cases, Takayasu’s arteritis can be managed by medication. However, if it becomes severe enough, surgery may be necessary. If you are diagnosed with Takayasu’s arteritis, talk with your doctor to discuss the right treatment plan for you.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Takayasu arteritis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Takayasu arteritis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Takayasu arteritis" returned 202 free, full-text research articles on human participants. First 3 results:

Abdominal pain as the presenting symptom of Takayasu arteritis in an adolescent male: A case report.
 

Author(s): Shaobo Yang, Kuiran Dong, Shan Zheng

Journal: Medicine (Baltimore). 2018 Jun;97(26):e11326.

 

Takayasu arteritis (TA) is a chronic granulomatous inflammation affecting the aorta and its main branches. The clinical symptoms are mainly due to arterial claudication and end-organ ischaemia. Abdominal pain is an uncommon manifestation of TA.

Last Updated: 31 Dec 1969

Go To URL
Takayasu arteritis-related photic and postprandial amaurosis.
 

Author(s): Sze H Wong, Roger E Turbin, Larry P Frohman

Journal:

 

We report the case of a 66-year-old man with Takayasu arteritis who developed photic and postprandial amaurosis occurring at a corticosteroid dose <40 mg per day, despite concurrent methotrexate. The amaurosis resolved with correction of anemia by packed red blood cell transfusion. ...

Last Updated: 31 Dec 1969

Go To URL
Evaluation of takayasu arteritis with delayed contrast-enhanced MR imaging by a free-breathing 3D IR turbo FLASH.
 

Author(s): Min Liu, Weifang Liu, Haoyuan Li, Xiaoming Shu, Xincao Tao, Zhenguo Zhai

Journal: Medicine (Baltimore). 2017 Dec;96(51):e9284.

 

The primary aim of our case-control study was to observe delayed contrast-enhanced magnetic resonance imaging (DCE-MRI) in patients with Takayasu arteritis (TA) in comparison with magnetic resonance angiography (MRA). Twenty-seven patients including 15 with active TA and 12 with stable ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Takayasu arteritis" returned 13 free, full-text review articles on human participants. First 3 results:

Takayasu arteritis presented with acute heart failure: case report and review of literature.
 

Author(s): Xuanqi An, Yechen Han, Bingqing Zhang, Lin Qiao, Yuxing Zhao, Xiaoxiao Guo, Ligang Fang, Wenling Zhu, Quan Fang, Zhujun Shen, Shuyang Zhang

Journal: ESC Heart Fail. 2017 11;4(4):649-654.

 

Acute heart failure due to myocarditis is not common in Takayasu arteritis, let alone in combination with thrombosis affecting both ventricles and pulmonary arteries. The concomitant infection of non-tuberculosis mycobacterium further complicates the clinical scenario and poses challenges ...

Last Updated: 31 Dec 1969

Go To URL
Endovascular balloon angioplasty versus stenting in patients with Takayasu arteritis: A meta-analysis.
 

Author(s): Han Saem Jeong, Jae Hyun Jung, Gwan Gyu Song, Sung Jae Choi, Soon Jun Hong

Journal: Medicine (Baltimore). 2017 Jul;96(29):e7558.

 

Symptomatic or significant vascular lesions of Takayasu arteritis (TA) need interventions. Although percutaneous transluminal angioplasty with balloon is a less invasive and safe method, stent implantation in TA can be an alternative option. However, superiority between balloon angioplasty ...

Last Updated: 31 Dec 1969

Go To URL
The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis.
 

Author(s): Danping Dai, YangYang Wang, Haiying Jin, Yiyang Mao, Hao Sun

Journal: Rheumatol. Int.. 2017 Jul;37(7):1083-1088.

 

The purpose of this study is to assess the effectiveness of mycophenolate mofetil (MMF) in treating Takayasu arteritis (TA) patients. Embase, Cochrane Library, Pubmed, Clinicaltrials. Gov and three Chinese literature databases (VIP, CNKI, WanFang) were searched; randomized-controlled ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

China Takayasu Arteritis Registry (CTA Registry)
 

Status: Recruiting

Condition Summary: TAKAYASU ARTERITIS

 

Last Updated: 13 Nov 2016

Go to URL
Registration Study of Takayasu's Arteritis in China
 

Status: Not yet recruiting

Condition Summary: Takayasu Arteritis

 

Last Updated: 23 Jun 2017

Go to URL
Takayasu Arteritis Clinical Trial in China
 

Status: Recruiting

Condition Summary: Takayasu Arteritis

 

Last Updated: 14 Mar 2018

Go to URL